Mojgan Karimi‐Zarchi

ORCID: 0000-0002-8734-9971 · 6 papers in corpus · active 2011-2022

Study types

  • article 5
  • other 1

Condition tags

  • endometriosis 3
  • dysmenorrhea 1
  • dyspareunia 1
other 2022
JMIR medical informatics ·doi:10.2196/34753

BACKGROUND: Cervical cancer has been recognized as a preventable type of cancer. As the assessment of all the risk factors of a disease is challenging for physicians, information technology and risk assessment models have been used to estim…

article 2018
International journal of reproductive biomedicine ·doi:10.29252/ijrm.16.8.501

BACKGROUND: gene which is expressed in the endometrium in response to steroid hormones. OBJECTIVE: gene expression in both endometrial ectopic and eutopic tissues in patients with endometriosis compared to the control samples. MATERIALS AND…

article 2018

Background: The study of microRNA expression can be effective in the diagnosing and treating different diseases. miR-135a is one of the most important micro-ribonucleic acids involved in endometriosis. Among the genes that become the target…

article 2016
International journal of reproductive biomedicine ·doi:10.29252/ijrm.14.11.713

BACKGROUND: Cancer antigen 125 (CA-125) is a glycoprotein biomarker that is used in women with pelvic masses such as endometriosis and maybe is useful in practice of patients suspicious to endometriosis. OBJECTIVE: The aim of this study was…

article 2016
·doi:10.59566/ijbs.2016.12105

BACKGROUND AND AIM: Abnormal uterine bleeding is one of the most common debilitating menstrual problems. The first therapeutic strategy for abnormal uterine bleeding is drug treatment. This study was, therefore, designed to determine the ef…

article 2011